+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Antifungal Drug Market Research Report by Infection Type (Superficial Fungal Infection and Systemic Fungal infection), Type, Form, Therapeutic Indications, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5337228
  • Report
  • April 2022
  • Region: Global
  • 210 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abbott Laboratories
  • Cipla, Inc.
  • G&W Laboratories LLC
  • Johnson & Johnson
  • Lakewood-Amedex, Inc.
  • Novartis AG
The Global Antifungal Drug Market size was estimated at USD 13.26 billion in 2021, USD 14.04 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.09% to reach USD 18.91 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Antifungal Drug to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Infection Type, the market was studied across Superficial Fungal Infection and Systemic Fungal infection.
  • Based on Type, the market was studied across Allylamines, Azoles, Echinocandins, and Polyenes. The Allylamines is further studied across Butenafine, Naftifine, and Terbinafine. The Azoles is further studied across Imidazoles, Thiazoles, and Voricanazole. The Echinocandins is further studied across Anidulafungin, Caspofungin, and Micafungin. The Polyenes is further studied across Amphotericin B, Candicidin, Hamycin, and Natamycin.
  • Based on Form, the market was studied across Ointments, Powder, and Tablets.
  • Based on Therapeutic Indications, the market was studied across Aspergillosis, Candidiasis, and Dermatophytosis.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Antifungal Drug market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antifungal Drug Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Antifungal Drug Market, including Abbott Laboratories, Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals LLC, Cadila Pharmaceuticals Limited, Cipla, Inc., Eli Lilly and Company, Enzon Pharmaceuticals, Inc., G&W Laboratories LLC, Gilead Sciences, Inc., Johnson & Johnson, Kramer Laboratories, Inc., Lakewood-Amedex, Inc., Merck KGaA, Novartis AG, Pfizer, Inc., Ranbaxy Laboratories Limited, Sanofi S.A., SCYNEXIS, Inc., Sigma-Aldrich, Inc., and Wockhardt Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Antifungal Drug Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antifungal Drug Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antifungal Drug Market?
4. What is the competitive strategic window for opportunities in the Global Antifungal Drug Market?
5. What are the technology trends and regulatory frameworks in the Global Antifungal Drug Market?
6. What is the market share of the leading vendors in the Global Antifungal Drug Market?
7. What modes and strategic moves are considered suitable for entering the Global Antifungal Drug Market?
Frequently Asked Questions about the Global Antifungal Drug Market

What is the estimated value of the Global Antifungal Drug Market?

The Global Antifungal Drug Market was estimated to be valued at $13.3 Billion in 2021.

What is the growth rate of the Global Antifungal Drug Market?

The growth rate of the Global Antifungal Drug Market is 6.0%, with an estimated value of $18.9 Billion by 2027.

What is the forecasted size of the Global Antifungal Drug Market?

The Global Antifungal Drug Market is estimated to be worth $18.9 Billion by 2027.

Who are the key companies in the Global Antifungal Drug Market?

Key companies in the Global Antifungal Drug Market include Abbott Laboratories, Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals LLC, Cadila Pharmaceuticals Limited, Cipla, Inc., Eli Lilly and Company, Enzon Pharmaceuticals, Inc., G&W Laboratories LLC and Johnson & Johnson.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Cipla, Inc.
  • G&W Laboratories LLC
  • Johnson & Johnson
  • Lakewood-Amedex, Inc.
  • Novartis AG

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of fungal infection due to climate
5.1.1.2. High awareness levels pertaining to myriad fungal infections
5.1.1.3. Increased demand for the drugs to combat the related diseases
5.1.1.4. Favorable government initiative and corporate funds
5.1.2. Restraints
5.1.2.1. Continued preference for conventional antifungal drugs
5.1.2.2. Growing population with antifungal drug resistance
5.1.3. Opportunities
5.1.3.1. Increased R&D funding and focus on product innovation
5.1.3.2. Patent expiration of branded drugs
5.1.4. Challenges
5.1.4.1. Potential side effects
5.1.4.2. Presence of counterfeit drugs and resistance toward antifungal drugs
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Antifungal Drug Market, by Infection Type
6.1. Introduction
6.2. Superficial Fungal Infection
6.3. Systemic Fungal infection
7. Antifungal Drug Market, by Type
7.1. Introduction
7.2. Allylamines
7.2.1. Butenafine
7.2.2. Naftifine
7.2.3. Terbinafine
7.3. Azoles
7.3.1. Imidazoles
7.3.2. Thiazoles
7.3.3. Voricanazole
7.4. Echinocandins
7.4.1. Anidulafungin
7.4.2. Caspofungin
7.4.3. Micafungin
7.5. Polyenes
7.5.1. Amphotericin B
7.5.2. Candicidin
7.5.3. Hamycin
7.5.4. Natamycin
8. Antifungal Drug Market, by Form
8.1. Introduction
8.2. Ointments
8.3. Powder
8.4. Tablets
9. Antifungal Drug Market, by Therapeutic Indications
9.1. Introduction
9.2. Aspergillosis
9.3. Candidiasis
9.4. Dermatophytosis
10. Americas Antifungal Drug Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Antifungal Drug Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Antifungal Drug Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Astellas Pharma Inc.
14.3. Bayer HealthCare Pharmaceuticals LLC
14.4. Cadila Pharmaceuticals Limited
14.5. Cipla, Inc.
14.6. Eli Lilly and Company
14.7. Enzon Pharmaceuticals, Inc.
14.8. G&W Laboratories LLC
14.9. Gilead Sciences, Inc.
14.10. Johnson & Johnson
14.11. Kramer Laboratories, Inc.
14.12. Lakewood-Amedex, Inc.
14.13. Merck KGaA
14.14. Novartis AG
14.15. Pfizer, Inc.
14.16. Ranbaxy Laboratories Limited
14.17. Sanofi S.A.
14.18. SCYNEXIS, Inc.
14.19. Sigma-Aldrich, Inc.
14.20. Wockhardt Limited
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ANTIFUNGAL DRUG MARKET: DYNAMICS
FIGURE 2. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2027
FIGURE 5. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 10. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2027
FIGURE 12. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, 2019-2027 (USD BILLION)
FIGURE 13. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 14. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, 2019-2027 (USD BILLION)
FIGURE 15. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 16. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, 2019-2027 (USD BILLION)
FIGURE 17. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, 2019-2027 (USD BILLION)
FIGURE 33. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, 2019-2027 (USD BILLION)
FIGURE 35. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, 2019-2027 (USD BILLION)
FIGURE 37. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 38. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, 2019-2027 (USD BILLION)
FIGURE 39. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 40. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, 2019-2027 (USD BILLION)
FIGURE 41. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 42. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, 2019-2027 (USD BILLION)
FIGURE 43. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 44. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, 2019-2027 (USD BILLION)
FIGURE 45. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 46. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2021 VS 2027 (%)
FIGURE 47. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2021 VS 2027 (USD BILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2027
FIGURE 49. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, 2019-2027 (USD BILLION)
FIGURE 50. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 51. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, 2019-2027 (USD BILLION)
FIGURE 52. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 53. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, 2019-2027 (USD BILLION)
FIGURE 54. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 55. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2021 VS 2027 (%)
FIGURE 56. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2021 VS 2027 (USD BILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2027
FIGURE 58. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, 2019-2027 (USD BILLION)
FIGURE 59. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 60. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, 2019-2027 (USD BILLION)
FIGURE 61. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 62. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, 2019-2027 (USD BILLION)
FIGURE 63. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 64. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. CANADA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. MEXICO ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. CHINA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. INDIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. JAPAN ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 76. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 77. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 78. SINGAPORE ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 79. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 80. TAIWAN ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 81. THAILAND ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 82. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 83. FRANCE ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 84. GERMANY ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 85. ITALY ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 86. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 87. QATAR ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 88. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 89. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 90. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 91. SPAIN ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 92. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 93. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 94. GLOBAL ANTIFUNGAL DRUG MARKET: FPNV POSITIONING MATRIX
FIGURE 95. GLOBAL ANTIFUNGAL DRUG MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 96. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIFUNGAL DRUG MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ANTIFUNGAL DRUG MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY INFECTION TYPE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
TABLE 15. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY REGION, 2019-2027 (USD BILLION)
TABLE 16. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 17. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY STATE, 2019-2027 (USD BILLION)
TABLE 18. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY ALLYLAMINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 20. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, BY REGION, 2019-2027 (USD BILLION)
TABLE 21. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, BY STATE, 2019-2027 (USD BILLION)
TABLE 23. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY BUTENAFINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, BY REGION, 2019-2027 (USD BILLION)
TABLE 26. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, BY STATE, 2019-2027 (USD BILLION)
TABLE 28. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY NAFTIFINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, BY REGION, 2019-2027 (USD BILLION)
TABLE 31. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, BY STATE, 2019-2027 (USD BILLION)
TABLE 33. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY TERBINAFINE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY REGION, 2019-2027 (USD BILLION)
TABLE 36. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY STATE, 2019-2027 (USD BILLION)
TABLE 38. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY AZOLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, BY REGION, 2019-2027 (USD BILLION)
TABLE 41. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, BY STATE, 2019-2027 (USD BILLION)
TABLE 43. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY IMIDAZOLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, BY REGION, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, BY STATE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY THIAZOLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, BY REGION, 2019-2027 (USD BILLION)
TABLE 51. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, BY STATE, 2019-2027 (USD BILLION)
TABLE 53. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY VORICANAZOLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2019-2027 (USD BILLION)
TABLE 56. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY STATE, 2019-2027 (USD BILLION)
TABLE 58. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY ECHINOCANDINS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 61. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 63. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY ANIDULAFUNGIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 66. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 68. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY CASPOFUNGIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 71. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 72. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 73. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY MICAFUNGIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 75. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY REGION, 2019-2027 (USD BILLION)
TABLE 76. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 77. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY STATE, 2019-2027 (USD BILLION)
TABLE 78. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY POLYENES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 80. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, BY REGION, 2019-2027 (USD BILLION)
TABLE 81. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 82. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, BY STATE, 2019-2027 (USD BILLION)
TABLE 83. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY AMPHOTERICIN B, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 85. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 86. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 87. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 88. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY CANDICIDIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 90. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 91. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 92. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 93. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY HAMYCIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 95. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 96. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 97. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 98. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY NATAMYCIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 100. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY FORM, 2019-2027 (USD BILLION)
TABLE 101. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 102. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 103. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 104. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 106. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY REGION, 2019-2027 (USD BILLION)
TABLE 107. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 108. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY STATE, 2019-2027 (USD BILLION)
TABLE 109. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY POWDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 111. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY REGION, 2019-2027 (USD BILLION)
TABLE 112. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 113. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY STATE, 2019-2027 (USD BILLION)
TABLE 114. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY TABLETS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 116. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2019-2027 (USD BILLION)
TABLE 117. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY REGION, 2019-2027 (USD BILLION)
TABLE 118. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 119. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY STATE, 2019-2027 (USD BILLION)
TABLE 120. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY ASPERGILLOSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 122. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY REGION, 2019-2027 (USD BILLION)
TABLE 123. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 124. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY STATE, 2019-2027 (USD BILLION)
TABLE 125. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY CANDIDIASIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 127. GLOBAL ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY REGION, 2019-2027 (USD BILLION)
TABLE 128. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 129. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY STATE, 2019-2027 (USD BILLION)
TABLE 130. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, BY DERMATOPHYTOSIS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 132. AMERICAS ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 133. ARGENTINA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 134. BRAZIL ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 135. CANADA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 136. MEXICO ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 137. UNITED STATES ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 138. ASIA-PACIFIC ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 139. AUSTRALIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 140. CHINA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 141. INDIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 142. INDONESIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 143. JAPAN ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 144. MALAYSIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 145. PHILIPPINES ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 146. SINGAPORE ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 147. SOUTH KOREA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 148. TAIWAN ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 149. THAILAND ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 151. FRANCE ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 152. GERMANY ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 153. ITALY ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 154. NETHERLANDS ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 155. QATAR ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 156. RUSSIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 157. SAUDI ARABIA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 158. SOUTH AFRICA ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 159. SPAIN ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 160. UNITED ARAB EMIRATES ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 161. UNITED KINGDOM ANTIFUNGAL DRUG MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 162. GLOBAL ANTIFUNGAL DRUG MARKET: SCORES
TABLE 163. GLOBAL ANTIFUNGAL DRUG MARKET: BUSINESS STRATEGY
TABLE 164. GLOBAL ANTIFUNGAL DRUG MARKET: PRODUCT SATISFACTION
TABLE 165. GLOBAL ANTIFUNGAL DRUG MARKET: RANKING
TABLE 166. GLOBAL ANTIFUNGAL DRUG MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 167. GLOBAL ANTIFUNGAL DRUG MARKET: MERGER & ACQUISITION
TABLE 168. GLOBAL ANTIFUNGAL DRUG MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 169. GLOBAL ANTIFUNGAL DRUG MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 170. GLOBAL ANTIFUNGAL DRUG MARKET: INVESTMENT & FUNDING
TABLE 171. GLOBAL ANTIFUNGAL DRUG MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 172. GLOBAL ANTIFUNGAL DRUG MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Bayer HealthCare Pharmaceuticals LLC
  • Cadila Pharmaceuticals Limited
  • Cipla, Inc.
  • Eli Lilly and Company
  • Enzon Pharmaceuticals, Inc.
  • G&W Laboratories LLC
  • Gilead Sciences, Inc.
  • Johnson & Johnson
  • Kramer Laboratories, Inc.
  • Lakewood-Amedex, Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer, Inc.
  • Ranbaxy Laboratories Limited
  • Sanofi S.A.
  • SCYNEXIS, Inc.
  • Sigma-Aldrich, Inc.
  • Wockhardt Limited
Note: Product cover images may vary from those shown

Loading
LOADING...